HCV-1 e2 Protein (554-569) (TFA)
HCV-1 e2 Protein (554-569) TFA is one of the main antigenic regions of HCV envelope 2 (e2) protein. The HCV-1 e2 Protein (554-569) TFA contains a putative N-glycosylation site, which was previously thought to influence the immune recognition of e2[1].
Product Specifications
UNSPSC
12352209
Target
HCV
Type
Peptides
Related Pathways
Anti-infection
Applications
COVID-19-anti-virus
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/hcv-1-e2-protein-554-569-tfa.html
Solubility
10 mM in DMSO
Smiles
O=C(N[C@@H](CCSC)C(N[C@@H](CC(N)=O)C(N[C@@H](CO)C(N[C@@H]([C@H](O)C)C(NCC(N[C@@H](CC1=CC=CC=C1)C(N[C@@H]([C@H](O)C)C(N[C@@H](CCCCN)C(N[C@@H](C(C)C)C(N[C@@H](CS)C(NCC(N[C@@H](C)C(N2[C@@H](CCC2)C(N3[C@@H](CCC3)C(N[C@@H](CS)C(O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)[C@H](CC4=CNC5=CC=CC=C45)N.OC(C(F)(F)F)=O.[x]
Molecular Formula
C74H111N19O21S3.xC2HF3O2
References & Citations
[1]Zhang ZX, et al. Antigenic structure of the hepatitis C virus envelope 2 protein. Clin Exp Immunol. 1994 Dec;98 (3) :382-7.
Shipping Conditions
Room temperature
Scientific Category
Peptides
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
